Lloyd Advisory Services, LLC.

Position in EXEL — Exelixis, Inc.

CIK 1802474 SUWANEE, GA

Position in EXEL

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$30,578

+$28,691 QoQ

Shares Held

562

+1177.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#629

of 751 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Lloyd Advisory Services, LLC. holds $121,678 across 4 Biotechnology names. EXEL ranks #3 (25.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	484	$54,866
2	RPRX	Royalty Pharma plc	619	$34,707
3	EXEL	Exelixis, Inc. This page	562	$30,578
4	CRSP	CRISPR Therapeutics AG	28	$1,527

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$30,578	562	+1177.3%	Shares	Sole	2026-08-07
2026-03-31	$1,887	44	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.